-
1
المؤلفون: M R McClung, A L Clark
المصدر: Climacteric. 25:60-66
مصطلحات موضوعية: medicine.medical_specialty, Abaloparatide, Osteoporosis, Romosozumab, Fractures, Bone, Bone Density, Teriparatide, osteoanabolic, medicine, Humans, abaloparatide, Intensive care medicine, Osteoporosis, Postmenopausal, romosozumab, Postmenopausal women, Bone Density Conservation Agents, Diphosphonates, business.industry, Obstetrics and Gynecology, General Medicine, sequence, medicine.disease, Menopause, Female, business, Very high risk, medicine.drug, Bone mass
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406e842e15797b728fdd9070ef88de0aTest
https://doi.org/10.1080/13697137.2021.1953463Test -
2
المؤلفون: B. Stollenwerk, K. Adachi, Shravanthi R. Gandra, Michael R. McClung, Kiyoshi Tanaka, H. Hagino, S. Silverman, M. Charokopou, B. Johnson
المصدر: Osteoporosis International. 32:2011-2021
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Cost effectiveness, Endocrinology, Diabetes and Metabolism, Osteoporosis, Romosozumab, 030209 endocrinology & metabolism, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Teriparatide, health care economics and organizations, romosozumab, teriparatide, Bone mineral, cost effectiveness, business.industry, Incidence (epidemiology), medicine.disease, osteoporosis, Relative risk, Cohort, 030101 anatomy & morphology, markov model, bone mineral density, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c7096ae651f3ad13239f8cea994fb1Test
https://doi.org/10.1007/s00198-021-05927-1Test -
3
المؤلفون: J C Forfar, Lorenz C. Hofbauer, Bente L. Langdahl
المصدر: Langdahl, B L, Hofbauer, L C & Forfar, J C 2021, ' Cardiovascular Safety and Sclerostin Inhibition ', The Journal of clinical endocrinology and metabolism, vol. 106, no. 7, pp. 1845-1853 . https://doi.org/10.1210/clinem/dgab193Test
مصطلحات موضوعية: 0301 basic medicine, Endocrinology, Diabetes and Metabolism, Clinical Biochemistry, Osteoporosis, sclerostin, Cardiovascular System, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Bone Density, Osteogenesis, Osteoporosis, Postmenopausal, Bone Density Conservation Agents, biology, Antibodies, Monoclonal, Middle Aged, medicine.anatomical_structure, Cardiovascular Diseases, RANKL, Female, Risk, medicine.medical_specialty, Romosozumab, 030209 endocrinology & metabolism, 03 medical and health sciences, cardiovascular safety, Osteoclast, Internal medicine, Product Surveillance, Postmarketing, medicine, Humans, Adverse effect, Adaptor Proteins, Signal Transducing, Proportional Hazards Models, romosozumab, business.industry, Biochemistry (medical), medicine.disease, osteoporosis, Clinical trial, 030104 developmental biology, Clinical Trials, Phase III as Topic, chemistry, Heart Disease Risk Factors, Relative risk, biology.protein, Sclerostin, business, Osteoporotic Fractures
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::735a36ada85530b408b68cbf207c2a06Test
https://doi.org/10.1210/clinem/dgab193Test -
4
المؤلفون: G Iolascon, M Annunziata, Luigi Laino, S Liguori, Gennaro Cecoro, L Guida, M Paoletta, F Gimigliano, Antimo Moretti, L Nastri, G Toro
المساهمون: Cecoro, G, Paoletta, M, Annunziata, M, Laino, L, Nastri, L, Gimigliano, F, Liguori, S, Toro, G, Moretti, A, Guida, L, Iolascon, G
المصدر: European Cells & Materials, Vol 41, Pp 316-331 (2021)
مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, 0206 medical engineering, MEDLINE, lcsh:Surgery, alveolar bone, 02 engineering and technology, Bone and Bones, chemistry.chemical_compound, Strontium ranelate, strontium ranelate, Tooth loss, medicine, Teriparatide, Animals, Humans, parathyroid hormone, Intensive care medicine, periodontitis, romosozumab, Periodontitis, teriparatide, business.industry, Periodontology, lcsh:RD1-811, medicine.disease, 020601 biomedical engineering, dkk-1 antibodies, Pharmaceutical Preparations, chemistry, Sclerostin, Animal studies, sclerostin antibodies, medicine.symptom, lcsh:RC925-935, business, calvarial bone defect, medicine.drug, Periodontitis, parathyroid hormone, teriparatide, strontium ranelate, romosozumab, calvarial bone defect, alveolar bone, DKK-1 antibodies, sclerostin antibodies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea61f3181d142ff713a568da467a50dTest
https://www.ecmjournal.org/papers/vol041/pdf/v041a20.pdfTest -
5
المؤلفون: Stéphane Horlait, Donald Betah, Jacques P. Brown, Cesar Libanati, Yifei Shi, Rogely W. Boyce, Erik Fink Eriksen, Pascale Chavassieux, Roland Chapurlat
المصدر: Journal of Bone and Mineral Research. 37:36-40
مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Osteoporosis, Romosozumab, Urology, Placebo, chemistry.chemical_compound, Bone Density, Osteogenesis, medicine, Humans, Orthopedics and Sports Medicine, Osteoporosis, Postmenopausal, Bone Density Conservation Agents, business.industry, Antibodies, Monoclonal, Middle Aged, medicine.disease, Resorption, Clinical trial, Denosumab, chemistry, Concomitant, Sclerostin, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe42f8075c8218191df7e01ef61cc7eTest
https://doi.org/10.1002/jbmr.4457Test -
6
المؤلفون: Takashi Sakai, Norihiro Nishida, Kiminori Yukata, Yuji Nagao, Atsushi Mihara, Ryuta Iwanaga, Kenzo Fujii, Toshihiro Seki
المصدر: World Journal of Orthopedics
مصطلحات موضوعية: medicine.medical_specialty, animal structures, Sclerostin antibody, Osteoporosis, Romosozumab, Fracture healing, Bone healing, Bone morphogenetic protein, Bone resorption, chemistry.chemical_compound, Internal medicine, Canonical Wnt-β-catenin pathway, Medicine, Orthopedics and Sports Medicine, Femur, Bone mineral, business.industry, fungi, Minireviews, medicine.disease, body regions, Endocrinology, chemistry, Sclerostin, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97a973dd3ec4482bf5201d086aca5ae0Test
https://doi.org/10.5312/wjo.v12.i9.651Test -
7
المؤلفون: Katsunori Ikari, Koichiro Yano, Takeshi Mochizuki, Ken Okazaki
المصدر: Osteoporosis and Sarcopenia
Osteoporosis and Sarcopenia, Vol 7, Iss 3, Pp 110-114 (2021)مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Osteoporosis, Urology, Romosozumab, Diseases of the musculoskeletal system, Disease activity, Bone mineral density, Medicine, Severe osteoporosis, In patient, Rheumatoid arthritis, skin and connective tissue diseases, Bone mineral, business.industry, General Medicine, General Chemistry, medicine.disease, Denosumab, RC925-935, Original Article, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::560b0f28a1761fa218b275bbfbe49941Test
https://doi.org/10.1016/j.afos.2021.08.001Test -
8
المؤلفون: Willem F. Lems, Hennie G. Raterman, Laura P. B. Elbers
المصدر: Drugs
Elbers, L P B, Raterman, H G & Lems, W F 2021, ' Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review ', Drugs, vol. 81, no. 14, pp. 1645-1655 . https://doi.org/10.1007/s40265-021-01587-xTestمصطلحات موضوعية: medicine.medical_specialty, Bone Density Conservation Agents, business.industry, Osteoporosis, Romosozumab, Review Article, medicine.disease, Bone remodeling, Discontinuation, Denosumab, Zoledronic acid, medicine.anatomical_structure, Bone Density, Internal medicine, medicine, Teriparatide, Humans, Pharmacology (medical), Bone Remodeling, business, Osteoporotic Fractures, Randomized Controlled Trials as Topic, medicine.drug, Femoral neck
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12a84808e5828eb1c382c5249746ced5Test
https://doi.org/10.1007/s40265-021-01587-xTest -
9
المؤلفون: J Sachin, J. N. Sharma, Siddhartha Dutta, Shoban Babu Varthya, Tarun Kumar, Sameer Khasbage, Surjit Singh
المصدر: Osteoporosis International. 33:1-12
مصطلحات موضوعية: Bone mineral, medicine.medical_specialty, business.industry, Endocrinology, Diabetes and Metabolism, Osteoporosis, Romosozumab, medicine.disease, Rheumatology, medicine.anatomical_structure, Meta-analysis, Internal medicine, Orthopedic surgery, medicine, Adverse effect, business, Femoral neck
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::24f52b7848f04ce9207c617dfceb76d4Test
https://doi.org/10.1007/s00198-021-06095-yTest -
10
المؤلفون: S Palacios
المصدر: Climacteric. 25:43-49
مصطلحات موضوعية: medicine.medical_specialty, Abaloparatide, Osteoporosis, Romosozumab, Anabolic Agents, Bone Density, Weight loss, Teriparatide, Internal medicine, medicine, Vitamin D and neurology, Humans, Osteoporosis, Postmenopausal, Bone Density Conservation Agents, Diphosphonates, business.industry, Obstetrics and Gynecology, General Medicine, medicine.disease, Denosumab, Quality of Life, Female, medicine.symptom, business, Osteoporotic Fractures, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ce69b2576bf2491c7dbb588bb0c000Test
https://doi.org/10.1080/13697137.2021.1951697Test